Savannah Resources (LON:SAV) Gets Barclays Capital Civerage with GBX 41.00 Target; 0 Bullish Analysts Covering China Cord Blood (CO)

Among 2 analysts covering China Cord Blood (NYSE:CO), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. China Cord Blood had 4 analyst reports since August 21, 2015 according to SRatingsIntel. Roth Capital maintained the stock with “Hold” rating in Friday, August 28 report. The company was downgraded on Friday, February 5 by Howard Weil. TH Capital maintained China Cord Blood Corporation (NYSE:CO) on Friday, August 21 with “Neutral” rating. See China Cord Blood Corporation (NYSE:CO) latest ratings:

Research professionals at Barclays Capital has begun coverage on Savannah Resources (LON:SAV) with a Overweight rating. The TP for SAV is exactly GBX 41.00. It would indicate a potential upside of 572.13% from company’s previous close.

China Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company has market cap of $1.19 billion. The firm offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. It has a 27.9 P/E ratio. As of March 31, 2017, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province.

The stock decreased 1.87% or $0.2 during the last trading session, reaching $10.52. About 70,410 shares traded. China Cord Blood Corporation (NYSE:CO) has risen 28.22% since February 19, 2017 and is uptrending. It has outperformed by 11.52% the S&P500.

Investors sentiment decreased to 2.27 in Q3 2017. Its down 0.06, from 2.33 in 2017Q2. It turned negative, as 8 investors sold China Cord Blood Corporation shares while 7 reduced holdings. 20 funds opened positions while 14 raised stakes. 7.94 million shares or 17.53% more from 6.75 million shares in 2017Q2 were reported. Deutsche Financial Bank Ag reported 14,399 shares. 11,900 were accumulated by Bowen Hanes And. Peak6 Limited Partnership reported 175,657 shares stake. Parametric Assoc Ltd Liability Co has 0% invested in China Cord Blood Corporation (NYSE:CO) for 31,434 shares. Goldman Sachs Group holds 0% of its portfolio in China Cord Blood Corporation (NYSE:CO) for 19,136 shares. 124,531 are owned by Millennium Limited Liability. Envestnet Asset reported 235 shares. Lucus Advsrs Ltd Liability Corp invested in 0.51% or 32,535 shares. Ahl Prtn Ltd Liability Partnership stated it has 45,298 shares or 0.01% of all its holdings. Sg Americas Ltd, a New York-based fund reported 231,204 shares. Minnesota-based Us Bank & Trust De has invested 0% in China Cord Blood Corporation (NYSE:CO). Capstone Inv Ltd Com invested in 0% or 11,345 shares. Advisory Incorporated owns 25,468 shares or 0% of their US portfolio. Acadian Asset Management Ltd Llc has invested 0% in China Cord Blood Corporation (NYSE:CO). California Pub Employees Retirement Systems holds 0% or 182,609 shares in its portfolio.

Among 7 analysts covering Savannah Resources (LON:SAV), 6 have Buy rating, 1 Sell and 0 Hold. Therefore 86% are positive. Savannah Resources has GBX 125 highest and GBX 10.70 lowest target. GBX 51.54’s average target is 731.29% above currents GBX 6.2 stock price. Savannah Resources had 136 analyst reports since September 8, 2015 according to SRatingsIntel. The firm earned “Speculative Buy” rating on Monday, September 12 by Beaufort Securities. The stock of Savannah Resources Plc (LON:SAV) earned “Corporate” rating by Northland Capital on Friday, June 16. Beaufort Securities maintained the stock with “Speculative Buy” rating in Tuesday, February 28 report. FinnCap maintained the stock with “Corporate” rating in Wednesday, August 23 report. Northland Capital maintained the shares of SAV in report on Thursday, June 23 with “Corporate” rating. FinnCap maintained it with “Corporate” rating and GBX 11 target in Monday, September 25 report. Beaufort Securities maintained the shares of SAV in report on Tuesday, October 11 with “Speculative Buy” rating. As per Monday, February 12, the company rating was maintained by Beaufort Securities. On Thursday, July 28 the stock rating was maintained by Northland Capital with “Corporate”. Northland Capital maintained the shares of SAV in report on Thursday, October 26 with “Corporate” rating.

The stock increased 1.64% or GBX 0.1 during the last trading session, reaching GBX 6.2. About 182,261 shares traded. Savannah Resources Plc (LON:SAV) has 0.00% since February 19, 2017 and is . It has underperformed by 16.70% the S&P500.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: